Sphingomyelin accumulation has been related to type 2 diabetes and observed in mouse models of insulin resistance (Samad et al., 2006) as well as in the skeletal muscle of obese, insulin-resistant humans (Straczkowski et al., 2004). This evidence concerns the gene INS and type 2 diabetes mellitus.